Literature DB >> 17690898

Circulating neutrophils in Behçet disease is resistant for apoptotic cell death in the remission phase of uveitis.

Keita Fujimori1, Keiko Oh-i, Masaru Takeuchi, Naoyuki Yamakawa, Takaaki Hattori, Takeshi Kezuka, Hiroshi Keino, Jun Suzuki, Hiroshi Goto, Jun-ichi Sakai, Masahiko Usui.   

Abstract

BACKGROUND: Behçet disease (BD) is manifested by recurrent acute iridocyclitis with hypopyon in the active phase, which regresses spontaneously. Hypopyon consists of inflammatory cells infiltrating the eye, with polymorphonuclear cells (PMNs) as the main component. The present study was conducted to investigate the apoptosis property of PMNs in BD patients with uveitis.
METHODS: PMNs were purified from peripheral blood cells of BD patients with uveitis in the active or remission phase and were cultured for 12 hours. In some cultures, lipopolysaccharide (LPS), antagonistic anti-TNFalpha antibody, agonistic anti-Fas antibody, or Fas:Fc fusion protein was added. At the end of cultures, apoptotic cells were evaluated by Annexin V expression using flow cytometry.
RESULTS: Spontaneous apoptosis of PMNs showed lower levels in the remission phase of BD-related uveitis compared with the active phase or healthy controls. The lower level of PMN apoptosis in the remission phase of uveitis in BD remained even by stimulation with LPS, anti-TNFalpha antibody, or Fas:Fc fusion protein, which was abolished in the presence of agonistic anti-Fas antibody.
CONCLUSIONS: In BD patients, the apoptosis of PMNs was reduced in the remission phase of uveitis and restored in the active phase, which arose from the apoptotic cell death in part via Fas-Fas ligand interaction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17690898     DOI: 10.1007/s00417-007-0659-5

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  30 in total

1.  Behçet's disease and antibody titers to various heat-shock protein 60s.

Authors:  T Tanaka; N Yamakawa; N Koike; J Suzuki; F Mizuno; M Usui
Journal:  Ocul Immunol Inflamm       Date:  1999-06       Impact factor: 3.070

Review 2.  Behçet's disease: infectious aetiology, new autoantigens, and HLA-B51.

Authors:  H Direskeneli
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

Review 3.  Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.

Authors: 
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

4.  Fas ligand-induced apoptosis as a mechanism of immune privilege.

Authors:  T S Griffith; T Brunner; S M Fletcher; D R Green; T A Ferguson
Journal:  Science       Date:  1995-11-17       Impact factor: 47.728

5.  Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction.

Authors:  S M Kang; D B Schneider; Z Lin; D Hanahan; D A Dichek; P G Stock; S Baekkeskov
Journal:  Nat Med       Date:  1997-07       Impact factor: 53.440

6.  Microtubules in neutrophils of patients with Behçet's disease.

Authors:  T Saga; H Matsuda
Journal:  Jpn J Ophthalmol       Date:  1985       Impact factor: 2.447

7.  Neutrophil activation in Behçet's disease.

Authors:  E Eksioglu-Demiralp; H Direskeneli; A Kibaroglu; S Yavuz; T Ergun; T Akoglu
Journal:  Clin Exp Rheumatol       Date:  2001 Sep-Oct       Impact factor: 4.473

8.  Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products.

Authors:  F Colotta; F Re; N Polentarutti; S Sozzani; A Mantovani
Journal:  Blood       Date:  1992-10-15       Impact factor: 22.113

9.  Inhibition by bacterial lipopolysaccharide of spontaneous and TNF-alpha-induced human neutrophil apoptosis in vitro.

Authors:  O Hachiya; Y Takeda; H Miyata; H Watanabe; T Yamashita; F Sendo
Journal:  Microbiol Immunol       Date:  1995       Impact factor: 1.955

10.  Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease.

Authors:  Cem Evereklioglu; Hamdi Er; Yusuf Türköz; Mustafa Cekmen
Journal:  Mediators Inflamm       Date:  2002-04       Impact factor: 4.711

View more
  4 in total

1.  Effect of different cytokines in combination with IL-15 on the expression of activating receptors in NK cells of patients with Behçet's disease.

Authors:  Nilgun Sallakci; Ilhan Tahrali; Umut Can Kucuksezer; Esin Aktas Cetin; Ahmet Gul; Gunnur Deniz
Journal:  Immunol Res       Date:  2022-06-03       Impact factor: 4.505

2.  Decreased neutrophil apoptosis in quiescent ANCA-associated systemic vasculitis.

Authors:  Mohamed Abdgawad; Åsa Pettersson; Lena Gunnarsson; Anders A Bengtsson; Pierre Geborek; Lars Nilsson; Mårten Segelmark; Thomas Hellmark
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

Review 3.  Immunopathogenesis of ocular Behçet's disease.

Authors:  Un Chul Park; Tae Wan Kim; Hyeong Gon Yu
Journal:  J Immunol Res       Date:  2014-07-02       Impact factor: 4.818

4.  Gene Expression Profiling in Behcet's Disease Indicates an Autoimmune Component in the Pathogenesis of the Disease and Opens New Avenues for Targeted Therapy.

Authors:  Antonio Puccetti; Piera Filomena Fiore; Andrea Pelosi; Elisa Tinazzi; Giuseppe Patuzzo; Giuseppe Argentino; Francesca Moretta; Claudio Lunardi; Marzia Dolcino
Journal:  J Immunol Res       Date:  2018-04-24       Impact factor: 4.818

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.